Foley Catheters - Market Insights, Competitive Landscape, and Market Forecast - 2030

Foley Catheters - Market Insights, Competitive Landscape, and Market Forecast - 2030

Foley Catheters Market By Product Type (2-Way, 3-Way, And 4-Way), Material (Sclicon, Latex, And Others), Applications (Bladder Cancer, Urinary Stone Disease, Prostate Conditions, And Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady cagr forecast till 2030 owing to rise in the prevalence of urological disorders, and increasing demand for antimicrobial catheters

The foley catheters market was valued at USD 1.44 billion in 2023 and is likely to register a CAGR of 8.78% during the forecast period from 2024 to 2030 to reach USD 2.38 billion by 2030. The demand for Foley catheters is primarily being boosted by several key factors. Firstly, the global aging population is increasing, leading to a higher prevalence of conditions such as urinary retention, urinary incontinence, urinary tract infections (UTIs), urinary stone disease, bladder cancer, and benign prostatic hyperplasia (BPH), which often necessitate the use of foley catheters for urinary drainage. Additionally, advancements in healthcare technologies and procedures have expanded the indications for Foley catheters, making them essential in various medical settings, including hospitals, nursing homes, and home healthcare. Moreover, the rising incidence of chronic diseases such as diabetes and neurological disorders has led to an increased need for long-term urinary catheterization, further driving market demand. Furthermore, the shift towards minimally invasive medical interventions has favored the use of Foley catheters over more invasive procedures for urinary management. Overall, these factors contribute to the growing demand for foley catheters during the forecast period of 2024 to 2030.

Foley Catheters Market Dynamics:

According to the data provided by The International Agency for Research Cancer (IARC) 2024, the global cancer burden has increased significantly, reaching an estimated 19.9 million cases in 2022 and this number is expected to reach 32.6 million cases by 2045. Bladder cancer has seen a rise in its ranking, moving up from the 10th to the 9th most diagnosed cancer worldwide. The latest data indicates that 614,298 individuals were diagnosed with bladder cancer in 2022, representing a 7.1% increase from the figures reported in 2020 and this number is expected to reach 1,115,460 new cases by 2045.

Bladder cancer is the sixth most common cancer among men and is estimated to affect 523,674 new male cases annually, accounting for 5.4% of all new cancer cases in men worldwide. Bladder cancer patients often require a range of treatments, including chemotherapy and radiation therapy, which can affect their urinary function. These treatments may cause side effects such as urinary retention or incontinence, leading to the need for Foley catheters for symptom management and patient care. Therefore, the prevalence of bladder cancer will lead to an increase in the market growth of Foley catheters.

Additionally, according to various studies conducted in 2023, urinary tract infections (UTIs) rank as the second most common infectious disease globally, affecting over 150 million individuals annually. UTIs, especially those arising from catheter use, often necessitate the frequent replacement of catheters in hospitals, thereby driving up demand. This increased demand has spurred the development of safer catheter designs, including those with antimicrobial coatings, aimed at reducing the risk of infection. Healthcare guidelines now prioritize the prevention of catheter-associated UTIs (CAUTIs), prompting hospitals to adopt these safer catheter options. The increasing prevalence of UTIs leading to higher hospitalization rates is expected to further elevate the demand for catheters in healthcare facilities, consequently fostering growth in the overall market for Foley catheters.

The growth of the Foley catheters market is being driven by several key factors, one of which is the increasing number of product approvals. In November 2021, The Flume Catheters Company Ltd. (TFCC), a medical device company that aims to provide a better alternative to traditional Foley catheters, announced that it had received clearance from the U.S. Food and Drug Administration (FDA) to sell FLUME catheters in the United States.

Therefore, the demand for foley catheters is likely to increase which is expected to propel the growth of the overall foley catheters market during the forecast period from 2024 to 2030.

However, side effects associated with Foley catheters such as catheter displacements, and bladder spasms may restrict the growth of the overall foley catheters market.

Foley Catheters Market Segment Analysis:

Foley Catheters Market by Product Type (2-way, 3-way, and 4-way), Material (Silicon, Latex, and others), Applications (Bladder Cancer, Urinary Stone Disease, Prostate Conditions, and others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type segment of the overall Foley catheters market, the 2-way category is expected to hold the largest share in the year 2023. The large share of this segment is attributed to the greater demand for 2-way Foley catheters among end users due to the significant requirement in the medical field. This type of catheter is beneficial for its secure placement, the balloon, which helps prevent accidental dislodgment. It effectively drains urine, making it useful for patients with urinary retention, bladder outlet obstruction, or those needing continuous urine output monitoring. The design allows for easy insertion and removal, providing versatility in various clinical scenarios, from post-surgical care to critical care settings. The continuous drainage capability facilitates accurate urine output monitoring, aiding healthcare providers in patient management. Moreover, the 2-way Foley catheters can bring relief to patients with urinary retention, helping to prevent complications such as urinary tract infections and bladder damage. However, these advantages make 2-way foley catheters a preferred choice for surgeons and healthcare facilities.

For example, in January 2023, Bactiguard obtained its first MDR (Medical Device Regulations 2017/745) product approval after a thorough authorization process. The approval is for the latex BIP foley catheter, an indwelling urinary catheter that uses Bactiguard's distinctive infection prevention technology.

Therefore, owing to the aforementioned advantages associated with the 2 way catheter, it is expected to drive the demand for foley catheters, thereby propelling the overall market for foley catheters during the forecast period from 2024–2030

North America Is Expected To Dominate The Overall Foley Catheters Market:

Among all the regions, North America is expected to hold the largest share of the global Foley catheters market in 2023. Firstly, the region has a large aging population, which is more susceptible to urological conditions requiring urinary catheterization, such as urinary retention, urinary incontinence, benign prostatic hyperplasia (BPH), urinary stone disease, and bladder cancer among others in the region. Moreover, advancements in healthcare infrastructure, technology, and procedures in the region have expanded the indications for Foley catheters, making them essential in various medical settings. Overall, these factors contribute to the growing demand for Foley catheters in the North America market.

According to data from the National Institute of Diabetes and Digestive and Kidney Diseases in 2023, urinary stone disease affects a significant number of individuals in the United States. Among individuals aged 18-64, there are approximately 64,641 cases, and there are 1,105,848 cases among those aged 65 and older.

Surgical interventions to address urinary stone disease, such as ureteroscopy, percutaneous nephrolithotomy (PCNL), or shock wave lithotripsy (SWL), often necessitate the use of Foley catheters for managing urine flow during and after procedures, as well as for monitoring complications such as bleeding or blockages from stone fragments. Consequently, the rising prevalence of urinary stone disease, or urolithiasis, is expected to drive the growth of the Foley catheter market in North America.

Furthermore, recent mergers, acquisitions, and partnerships among key market players in the region, such as the expansion of the partnership between Becton, Dickinson and Company (BD) and Bactiguard AB. In December 2023, Bactiguard Holding AB (publ.) announced an enhanced partnership with Becton Dickinson & Company (BD), a prominent global medical technology company. This collaboration represents Bactiguard's most enduring and robust license agreement to date. Under an interim agreement, BD has secured an exclusive global license for Bactiguard-coated Foley catheters, effective immediately. This agreement marks the initial phase of Bactiguard's strategy to transition away from its medical device portfolio. Overall, the convergence of these factors is poised to boost the growth of the Foley catheter market in North America during the forecast period from 2024 to 2030.

Foley Catheters Market Key Players:

Some of the key market players operating in the foley catheters market include ANGIPLAST PRIVATE LIMITED., BD, Cardinal Health, HEMC (Hospital Equipment Manufacturing Company), Advin Health Care, AdvaCare Pharma, Teleflex Incorporated, GWS Surgicals LLP, BACTIGUARD AB, Medtronic plc, Convatec Inc., B. Braun, Ribbel International Limited, Coloplast, Sterimed Group, Suzhou Sunmed Co., VOGT MEDICAL, Boston Scientific Corporation, Cook, Smiths Group plc, and others.

Recent Developmental Activities In The Foley Catheters Market:

In December 2022 CATHETRIX, is set to debut its catheter stabilizer at the Arab Health 2023 event in Dubai, UAE. This launch will focus on a device designed to prevent urinary tract infections (UTIs) and reduce accidental removal of Foley catheters.

In December 2023, HR Pharmaceuticals, Inc. (HRP) secured an Exclusive Commercial Agreement with Poiesis Medical LLC to license Poiesis's Dual Balloon Catheters (Duette™).

Key Takeaways From The Foley Catheters Market Report Study

Market size analysis for current foley catheters market size (2023), and market forecast for 6 years (2024 to 2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global foley catheters market.

Various opportunities available for the other competitor in the foley catheters market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current foley catheters market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for foley catheter market growth in the coming future?

Target Audience Who Can Be Benefited From This Foley Catheters Market Report Study

Foley Catheters market product providers

Research organizations and consulting companies

Foley Catheters related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and traders dealing in Foley Catheters

Various end-users who want to know more about the foley catheter market and the latest technological developments in the foley catheters market.

Frequently Asked Questions For The Foley Catheters Market:

1. What are foley catheters?

A Foley catheters is a medical device that helps drain urine from your bladder. Healthcare providers use Foley catheters if you have a condition that makes it difficult or impossible to pee.

2. What is the market for global foley catheters market?

The foley catheters market was valued at USD 1.44 billion in 2023 and is likely to register a CAGR of 8.78% during the forecast period from 2024 to 2030 to reach USD 2.38 billion by 2030.

3. What are the drivers for the global foley catheters market?

The demand for Foley catheters is primarily being boosted by several key factors. Firstly, the global aging population is increasing, leading to a higher prevalence of conditions such as urinary retention, urinary incontinence, urinary tract infections (UTIs), urinary stone disease, bladder cancer, and benign prostatic hyperplasia (BPH), which often necessitate the use of foley catheters for urinary drainage. Additionally, advancements in healthcare technologies and procedures have expanded the indications for Foley catheters, making them essential in various medical settings, including hospitals, nursing homes, and home healthcare. Moreover, the rising incidence of chronic diseases such as diabetes and neurological disorders has led to an increased need for long-term urinary catheterization, further driving market demand. Furthermore, the shift towards minimally invasive medical interventions has favored the use of Foley catheters over more invasive procedures for urinary management. Overall, these factors contribute to the growing demand for Foley catheters during the forecast period of 2024 to 2030.

4. Who are the key players operating in the global foley catheters market?

Some of the key market players operating in the Foley catheters market include ANGIPLAST PRIVATE LIMITED., BD, Cardinal Health, HEMC (Hospital Equipment Manufacturing Company), Advin Health Care, AdvaCare Pharma, Teleflex Incorporated, GWS Surgicals LLP, BACTIGUARD AB, Medtronic plc, Convatec Inc., B. Braun, Ribbel International Limited, Coloplast, Sterimed Group, Suzhou Sunmed Co., VOGT MEDICAL, Boston Scientific Corporation, Cook, Smiths Group plc, and others.

5. Which region has the highest share in the foley catheters market?

Among all the regions, North America is expected to hold the largest share of the global Foley catheters market in 2023. Firstly, the region has a large aging population, which is more susceptible to urological conditions requiring urinary catheterization, such as urinary retention, urinary incontinence, benign prostatic hyperplasia (BPH), urinary stone disease, and bladder cancer among others in the region. Moreover, advancements in healthcare infrastructure, technology, and procedures in the region have expanded the indications for Foley catheters, making them essential in various medical settings. Overall, these factors contribute to the growing demand for Foley catheters in the North America market.